Vicore Pharma Holding AB
STO:VICO

Watchlist Manager
Vicore Pharma Holding AB Logo
Vicore Pharma Holding AB
STO:VICO
Watchlist
Price: 8.19 SEK 2.12% Market Closed
Market Cap: 1.9B SEK
Have any thoughts about
Vicore Pharma Holding AB?
Write Note

Vicore Pharma Holding AB
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vicore Pharma Holding AB
Operating Expenses Peer Comparison

Comparables:
BIOG B
BONEX
VITR
SOBI
BIOA B

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Vicore Pharma Holding AB
STO:VICO
Operating Expenses
-kr329.8m
CAGR 3-Years
-16%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Operating Expenses
-kr508.9m
CAGR 3-Years
-17%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Operating Expenses
-kr658.5m
CAGR 3-Years
-35%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Operating Expenses
-kr5.6B
CAGR 3-Years
-131%
CAGR 5-Years
-66%
CAGR 10-Years
-39%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Operating Expenses
-kr14B
CAGR 3-Years
-23%
CAGR 5-Years
-21%
CAGR 10-Years
-23%
BioArctic AB
STO:BIOA B
Operating Expenses
-kr300.5m
CAGR 3-Years
-34%
CAGR 5-Years
-9%
CAGR 10-Years
N/A

See Also

What is Vicore Pharma Holding AB's Operating Expenses?
Operating Expenses
-329.8m SEK

Based on the financial report for Jun 30, 2024, Vicore Pharma Holding AB's Operating Expenses amounts to -329.8m SEK.

What is Vicore Pharma Holding AB's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-34%

Over the last year, the Operating Expenses growth was -23%. The average annual Operating Expenses growth rates for Vicore Pharma Holding AB have been -16% over the past three years , -34% over the past five years .

Back to Top